Chemistry and Immunoassay Testing

Award NoticeNo Set AsideAwarded

This federal contract opportunity has been awarded to on September 17, 2025.

Award Information

This solicitation resulted in an award to for approximately $814,370 on September 17, 2025. Similar contracts are typically issued by DEPT OF DEFENSE under 334516 (Analytical Laboratory Instrument Manufacturing).

Award Number
36F79719D0024
Award Amount
$814,370
Award Date
September 17, 2025

Key Takeaways

  • No response deadline specified - contact the agency for details
  • Set-aside for No Set Aside businesses
  • Work to be performed in CAMP PENDLETON, CA
  • Industry: Analytical Laboratory Instrument Manufacturing

Contract Details

Notice ID
HT941025N0148
Opportunity Type
Award Notice
Sub-Agency
DEFENSE HEALTH AGENCY (DHA)
Office
DEFENSE HEALTH AGENCY HCD WEST
Posted Date
Tuesday, December 9, 2025
Response Deadline
Not specified
PSC Code
6630
Set-Aside
No Set Aside
Place of Performance
CAMP PENDLETON, CA, 92055
Status
Active

Description

The Defense Health Agency Contracting Activity - San Diego (HT9410), 7700 Arlington Blvd., Falls Church, VA 22042 has awarded a firm-fixed price (FFP), supply contract. the supplies provide laboratory testing for the hospital. David Grant Medical Center (DGMC) requires two redundant analyzer platforms capable of performing Chemistry and Immunoassay testing. The system will include automation capabilities that will provide specimen loading, transporting, centrifugation, decapping, sealing, and archiving capabilities. The system will include a comprehensive data management software that will provide quality control, specimen management, data storage, auto-verification, and testing statistics capabilities. The Contractor shall provide all management, tools, parts, materials (including all rea

Why This Opportunity Matters

The Department of DEFENSE is seeking responses for analytical laboratory instrument manufacturing with a set-aside for No Set Aside businesses in CAMP PENDLETON, CA. This set-aside designation means eligible businesses face reduced competition from larger firms.